|
H2AFY expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6243799999982E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.996500E-04 |
| Normal-vs-Stage2 |
1.155260E-03 |
| Normal-vs-Stage3 |
1.081920E-02 |
| Normal-vs-Stage4 |
2.801800E-01 |
| Stage1-vs-Stage2 |
1.731980E-01 |
| Stage1-vs-Stage3 |
9.195800E-01 |
| Stage1-vs-Stage4 |
8.332600E-01 |
| Stage2-vs-Stage3 |
1.801400E-01 |
| Stage2-vs-Stage4 |
3.263200E-01 |
| Stage3-vs-Stage4 |
8.885800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.92070000000811E-05 |
| Normal-vs-AfricanAmerican |
7.365000E-04 |
| Normal-vs-Asian |
1.434820E-01 |
| Caucasian-vs-AfricanAmerican |
7.796000E-01 |
| Caucasian-vs-Asian |
4.198000E-01 |
| AfricanAmerican-vs-Asian |
4.937000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.423900E-04 |
| Normal-vs-Female |
6.25850000046668E-07 |
| Male-vs-Female |
7.600200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.779400E-03 |
| Normal-vs-Extreme_Weight |
7.819000E-04 |
| Normal-vs-Obese |
1.775060E-03 |
| Normal-vs-Extreme_Obese |
5.710200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.731000E-01 |
| Normal_Weight-vs-Obese |
9.561400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.912800E-01 |
| Extreme_Weight-vs-Obese |
7.098200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.893000E-01 |
| Obese-vs-Extreme_Obese |
3.883000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.303700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.5942000000011E-05 |
| Normal-vs-Age(61-80Yrs) |
2.214200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.158000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.627600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.834000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.054400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.807600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.499600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.464800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.61059999999847E-05 |
| Normal-VS-Type2 PRCC |
2.096200E-03 |
| Normal-VS-KIRP CIMP |
4.440400E-01 |
| Normal-VS-Unclassified PRCC |
9.73079999999626E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.934600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.374000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.530100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.044200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.448300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.582000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.002120E-02 |
| Normal-vs-N1 |
2.687900E-02 |
| Normal-vs-N2 |
8.827800E-02 |
| N0-vs-N1 |
5.245400E-01 |
| N0-vs-N2 |
7.778800E-01 |
| N1-vs-N2 |
9.699800E-01 |
|
|
